Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | APLNR | P35414 | 3/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL441905 | 0.81 | ALDH1A1 (0.43) | — | |
| SCHEMBL444363 | 0.79 | APLNR (0.41) | APLNR | |
| SCHEMBL20313799 | 0.76 | APLNR (0.38) | APLNR | |
| SCHEMBL28703350 | 0.70 | APLNR (0.50) | APLNR | |
| SCHEMBL20323315 | 0.67 | APLNR (0.38) | APLNR | |
| SCHEMBL15647857 | 0.67 | MMP2 (0.32) | — | |
| SCHEMBL1486693 | 0.66 | — | — | |
| SCHEMBL632418 | 0.66 | — | — | |
| SCHEMBL18226691 | 0.66 | — | — | |
| SCHEMBL1812674 | 0.64 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 270 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250041285-A1 | MODIFYING THE EXPRESSION LEVEL OF A GENE ENCODING AN CYCLOOXYGENASE ENZYME BY TREATING A HUMAN SUBJECT WITH A NITROXIDE | HABASH LOUIS (US) | 2025-02-06 | — | — | US | claimed |
| US-20240415826-A1 | MODULATING EXPRESSION LEVEL OF A GENE ENCODING AN UNCOUPLING PROTEIN BY TREATING A HUMAN SUBJECT WITH A NITROXIDE | HABASH LOUIS (US) | 2024-12-19 | — | — | US | claimed |
| US-12110271-B2 | Manufacturing method for 4-methoxypyrrole derivatives | DAEWOONG PHARMACEUTICAL CO., LTD. (KR) | 2024-10-08 | — | — | US | claimed |
| WO-2023229323-A1 | METHOD FOR PREPARING 6-METHOXYPYRIDIN-3-YL DERIVATIVE | 일동제약(주) | 2023-11-30 | — | — | WO | claimed |
| US-20230203091-A1 | GLYCOCONJUGATION PROCESS | PFIZER (US) | 2023-06-29 | — | — | US | claimed |
| CN-115710701-A | Chemical gold plating solution and application | 广东东硕科技有限公司 | 2023-02-24 | — | — | CN | claimed |
| WO-2022264971-A1 | METHOD FOR EVALUATING QUALITY OF SPERM | 国立大学法人東海国立大学機構 | 2022-12-22 | — | — | WO | claimed |
| US-20220378767-A1 | MODULATING EXPRESSION LEVEL OF A GENE ENCODING AN UNCOUPLING PROTEIN BY TREATING A HUMAN SUBJECT WITH A NITROXIDE | HABASH LOUIS (US) | 2022-12-01 | — | — | US | claimed |
| US-20220378771-A1 | MODIFYING THE EXPRESSION LEVEL OF A GENE ENCODING AN CYCLOOXYGENASE ENZYME BY TREATING A HUMAN SUBJECT WITH A NITROXIDE | HABASH LOUIS (US) | 2022-12-01 | — | — | US | claimed |
| CN-115108969-A | Efficient and migration-resistant antioxidant as well as preparation method and application thereof | 华南理工大学 | 2022-09-27 | — | — | CN | claimed |
| US-8138268-B2 | Adhesive composition, circuit connecting material, connecting structure for circuit member, and semiconductor device | HITACHI CHEMICAL COMPANY, LTD. (JP) | 2012-03-20 | — | — | US | claimed |
| US-20100240700-A1 | PROPHYLACTIC PRETREATMENT WITH ANTIOXIDANTS | MITOS PHARMACEUTICALS, INC. (US) | 2010-09-23 | — | — | US | claimed |
| US-20100041716-A1 | NITROXIDES FOR USE IN TREATING OR PREVENTING HYPERCHOLESTEROLEMIA | MITOS PHARMACEUTICALS, INC. | 2010-02-18 | — | — | US | claimed |
| US-20080293705-A1 | A1 ADENOSINE RECEPTOR ANTAGONISTS | ENDACEA, INC. (US) | 2008-11-27 | — | — | US | claimed |
| EP-0946557-B1 | A-1-ADENOSINE RECEPTOR ANTAGONISTS | ENDACEA INC (US) | 2006-01-11 | — | — | EP | claimed |
| US-6495687-B1 | ADENOSINE RECEPTORS ARE INVOLVED IN A VAST NUMBER OF PERIPHERAL AND CENTRAL REGULATORY MECHANISMS SUCH AS, FOR EXAMPLE, VASODILATION, CARDIAC DEPRESSION, INHIBITION OF LIPOLYSIS, INHIBITION OF INSULIN RELEASE AND POTENTIATION | ENDACEA, INC. | 2002-12-17 | — | — | US | claimed |
| EP-0983334-A1 | ENZYMATIC BLEACHING SYSTEM CONTAINING NEW COMPOUNDS FOR INTENSIFYING ENZYMATIC ACTION | Call, Krimhild (DE) | 2000-03-08 | — | — | EP | claimed |
| WO-1999001607-A2 | ENZYMATIC OXIDATION SYSTEM WITH NOVEL ENZYMATIC-EFFECT ENHANCING COMPOUNDS | CALL, KRIMHILD (DE) | 1999-01-14 | — | — | WO | claimed |
| WO-1998051772-A1 | ENZYMATIC BLEACHING SYSTEM CONTAINING NEW COMPOUNDS FOR INTENSIFYING ENZYMATIC ACTION | CALL, KRIMHILD (DE) | 1998-11-19 | — | — | WO | claimed |
| EP-0327263-B1 | Hair growth stimulation with nitroxide and other radicals | PROCTOR PETER H (US) | 1994-09-07 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100041716-A1 | NITROXIDES FOR USE IN TREATING OR PREVENTING HYPERCHOLESTEROLEMIA | TXNRD2, TET1, TXNRD3 | APLNR 3286/4885 |
| US-20220378767-A1 | MODULATING EXPRESSION LEVEL OF A GENE ENCODING AN UNCOUPLING PROTEIN BY TREATING A HUMAN SUBJECT WITH A NITROXIDE | TXNRD2, TXN2, TXNRD1 | APLNR 1889/4885 |
| US-20250041285-A1 | MODIFYING THE EXPRESSION LEVEL OF A GENE ENCODING AN CYCLOOXYGENASE ENZYME BY TREATING A HUMAN SUBJECT WITH A NITROXIDE | HMOX2, QSOX1, GPX1 | APLNR 2550/4885 |
| US-20080293705-A1 | A1 ADENOSINE RECEPTOR ANTAGONISTS | ADORA1, ADORA2A, ADORA3 | APLNR 267/4885 |
| US-20100240700-A1 | PROPHYLACTIC PRETREATMENT WITH ANTIOXIDANTS | GPX1, GPX4, SOD1 | APLNR 3942/4885 |
| US-12110271-B2 | Manufacturing method for 4-methoxypyrrole derivatives | COMT, TH, HPD | APLNR 4804/4885 |
| US-20220378771-A1 | MODIFYING THE EXPRESSION LEVEL OF A GENE ENCODING AN CYCLOOXYGENASE ENZYME BY TREATING A HUMAN SUBJECT WITH A NITROXIDE | HMOX2, QSOX1, GPX1 | APLNR 2550/4885 |
| US-20240415826-A1 | MODULATING EXPRESSION LEVEL OF A GENE ENCODING AN UNCOUPLING PROTEIN BY TREATING A HUMAN SUBJECT WITH A NITROXIDE | TXNRD2, TXN2, TXNRD1 | APLNR 1889/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.